These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 24201398

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
    Campos C, Perrey A, Lambert C, Pereira B, Goutte M, Dubois A, Goutorbe F, Dapoigny M, Bommelaer G, Hordonneau C, Buisson A.
    Dig Dis Sci; 2017 Jun; 62(6):1628-1636. PubMed ID: 28401425
    [Abstract] [Full Text] [Related]

  • 23. Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn's Disease.
    Kotze PG, Saab MP, Saab B, da Silva Kotze LM, Olandoski M, Pinheiro LV, Martinez CA, Ayrizono ML, Magro DO, Coy CS.
    Dig Dis Sci; 2017 Feb; 62(2):456-464. PubMed ID: 27933472
    [Abstract] [Full Text] [Related]

  • 24. Postoperative Morbidity Risks Following Ileocolic Resection for Crohn's Disease Treated With Anti-TNF Alpha Therapy: A Retrospective Study of 360 Patients.
    Jouvin I, Lefevre JH, Creavin B, Pitel S, Chafai N, Tiret E, Beaugerie L, Parc Y, Saint-Antoine IBD Network.
    Inflamm Bowel Dis; 2018 Jan 18; 24(2):422-432. PubMed ID: 29361093
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease.
    Guizzetti L, Zou G, Khanna R, Dulai PS, Sandborn WJ, Jairath V, Feagan BG.
    J Crohns Colitis; 2018 Jan 24; 12(2):167-177. PubMed ID: 29028958
    [Abstract] [Full Text] [Related]

  • 27. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW, Bickston SJ.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD006893. PubMed ID: 18254120
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].
    Bor R, Farkas K, Bálint A, Szűcs M, Abrahám S, Baradnay G, Wittmann T, Szepes Z, Nagy F, Molnár T.
    Orv Hetil; 2013 Dec 08; 154(49):1943-8. PubMed ID: 24292112
    [Abstract] [Full Text] [Related]

  • 30. Medical versus surgical management of penetrating Crohn's disease: the current situation and future perspectives.
    Patil SA, Cross RK.
    Expert Rev Gastroenterol Hepatol; 2017 Sep 08; 11(9):843-848. PubMed ID: 28633544
    [Abstract] [Full Text] [Related]

  • 31. What Is the Risk of Anastomotic Leak After Repeat Intestinal Resection in Patients With Crohn's Disease?
    Johnston WF, Stafford C, Francone TD, Read TE, Marcello PW, Roberts PL, Ricciardi R.
    Dis Colon Rectum; 2017 Dec 08; 60(12):1299-1306. PubMed ID: 29112566
    [Abstract] [Full Text] [Related]

  • 32. Anti-TNF and Postoperative Complications in Abdominal Crohn's Disease Surgery.
    Yamamoto T, Teixeira FV, Saad-Hossne R, Kotze PG, Danese S.
    Curr Drug Targets; 2019 Dec 08; 20(13):1339-1348. PubMed ID: 30947671
    [Abstract] [Full Text] [Related]

  • 33. Intra-abdominal Sepsis After Ileocolic Resection in Crohn's Disease: The Role of Combination Immunosuppression.
    McKenna NP, Habermann EB, Glasgow AE, Dozois EJ, Lightner AL.
    Dis Colon Rectum; 2018 Dec 08; 61(12):1393-1402. PubMed ID: 30303885
    [Abstract] [Full Text] [Related]

  • 34. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease.
    Bafford AC, Powers S, Ha C, Kruse D, Gorfine SR, Chessin DB, Bauer JJ.
    J Clin Gastroenterol; 2013 Jul 08; 47(6):491-5. PubMed ID: 23090048
    [Abstract] [Full Text] [Related]

  • 35. Safety and Efficacy of Anti-TNFα Treatment in Crohn's Disease Patients with Abdominal Abscesses.
    Ibáñez-Samaniego L, Díaz-Fontenla F, Miranda-Bautista José, Acosta C, Barceló I, Flores V, Echenagusía M, Camúñez F, Díaz-Redondo A, Marín-Jiménez I, Menchén L.
    Hepatogastroenterology; 2015 May 08; 62(139):647-52. PubMed ID: 26897946
    [Abstract] [Full Text] [Related]

  • 36. Stapled anastomosis versus hand-sewn anastomosis of gastro/duodenojejunostomy in pancreaticoduodenectomy: A systematic review and meta-analysis.
    Hajibandeh S, Hajibandeh S, Khan RMA, Malik S, Mansour M, Kausar A, Subar D.
    Int J Surg; 2017 Dec 08; 48():1-8. PubMed ID: 28987557
    [Abstract] [Full Text] [Related]

  • 37. Does a histologically inflamed resection margin increase postoperative complications in patients with Crohn's disease?
    Aaltonen G, Ristimäki A, Keränen I, Carpelan-Holmström M, Lepistö A.
    Scand J Gastroenterol; 2018 Mar 08; 53(3):279-283. PubMed ID: 29431516
    [Abstract] [Full Text] [Related]

  • 38. Predictive parameters of early postoperative complications in Crohn's disease: Single team experience.
    Atasoy D, Aghayeva A, Bilgin İA, Erzin Y, Bayraktar İE, Baca B, Karahasanoğlu T, Hamzaoğlu İ.
    Turk J Gastroenterol; 2018 Jul 08; 29(4):406-410. PubMed ID: 30249554
    [Abstract] [Full Text] [Related]

  • 39. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn's disease.
    Simillis C, Purkayastha S, Yamamoto T, Strong SA, Darzi AW, Tekkis PP.
    Dis Colon Rectum; 2007 Oct 08; 50(10):1674-87. PubMed ID: 17682822
    [Abstract] [Full Text] [Related]

  • 40. [Analysis of risk factors for anastomotic infectious complications following bowel resection for Crohn disease].
    Wang WY, Chen CL, Chen GL, Wu CJ, Li HG, Luan SM, Zhu YB.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Apr 08; 16(4):328-31. PubMed ID: 23608792
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.